Alnylam Pharmaceuticals, a fast-growing biopharma that helps patients suffering from rare diseases, relies on a strong customer data foundation to connect and develop more impactful relationships with the most relevant doctors. Through this data-driven strategy, they are improving their targeting, their engagement with the healthcare ecosystem, and ultimately, their ability to deliver innovative therapies to patients.